CCG-100602 is primarily utilized in biochemical research to study its role as an inhibitor of Rho signaling pathways. It is particularly effective in investigating cellular processes such as cytoskeleton reorganization, cell migration, and adhesion. Researchers employ this compound to explore its potential in modulating gene expression linked to Rho-associated pathways, which are critical in various physiological and pathological conditions. Additionally, CCG-100602 is used in experimental studies to understand its impact on cancer cell behavior, including proliferation and metastasis, making it a valuable tool in oncology research. Its application extends to pharmacological studies aiming to develop targeted therapies for diseases influenced by Rho signaling.